Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre
Postchemotherapy RPLND remains an integral part of management of testicular tumours. Nerve-sparing techniques can minimize the ejaculatory dysfunction due to the procedure. We report our functional and oncological outcomes for nerve-sparing RPLND in postchemotherapy settings. We analysed data from a...
Gespeichert in:
| Veröffentlicht in: | Indian journal of surgical oncology 2021-06, Vol.12 (2), p.374-377 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 377 |
|---|---|
| container_issue | 2 |
| container_start_page | 374 |
| container_title | Indian journal of surgical oncology |
| container_volume | 12 |
| creator | Raja, Anand Malik, Kanuj Kathiresan, N. Radhakrishnan, Venkatraman |
| description | Postchemotherapy RPLND remains an integral part of management of testicular tumours. Nerve-sparing techniques can minimize the ejaculatory dysfunction due to the procedure. We report our functional and oncological outcomes for nerve-sparing RPLND in postchemotherapy settings. We analysed data from all patients undergoing nerve-sparing PC RPLND from January 1990 to December 2013 at our institute. Antegrade ejaculation and fertility issues were determined by patient history. Nerve sparing was achieved in 30% of patients undergoing PC RPLND. Of the 33 patients who underwent nerve-sparing PC RPLND, 19 (57.8%) had antegrade ejaculation. The mean time to antegrade ejaculation was 6.8 months. After a median follow-up of 75.61 months, 5-year disease-free survival was 98%. Nerve-sparing RPLND can improve functional outcomes without increasing recurrence rates in post chemotherapy setting. |
| doi_str_mv | 10.1007/s13193-021-01313-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8272781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2550056147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-3fcff3338dcf58657b21faadbff5cec282062996c906e9b9c065df0886a0ddd3</originalsourceid><addsrcrecordid>eNp9Ustu1DAUjRCIVqU_wMoSm7II-DF2YhZIKC0FaTSMyuwtj3PdcTW2g51UnZ_hW3E6FQgWeOMr33POffhU1WuC3xGMm_eZMCJZjSmpcQlZLZ9Vp1g2ohaS0-ePMa8bwclJdZ7zHS6HSbbA8mV1whZUctyS0-rnCtI91N8HnVy4ReuYR7MDH8cdJD0c0A2MKQ6Q3BgD6D1aHvywQ6vYA7p0OYMZXQzoYt2hm_VydfkW2ZhKOmTwLkSvxzhldA3Jow72e7SZfJzSB3T1MGtCMIBsih5ptIE0Op0OqNPlNRV4GBO8ql5Yvc9w_nSfVZvPV5vuS738dv21-7SszYKTsWbWWMsYa3tjeSt4s6XEat1vreUGDG0pFlRKYSQWILfSYMF7i9tWaNz3PTurPh5lh2nroTdzbb1XQ3K-tKSidurvTHA7dRvvVUsb2rSkCFw8CaT4Y4I8Ku-yKRPrAGUDinLOCW5kgwv0zT_Qu7KSUKabURhzQRZNQdEjyqSYcwL7uxmC1WwAdTSAKgZQjwZQspDYkZSH-Tch_ZH-D-sX5xK05w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550056147</pqid></control><display><type>article</type><title>Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre</title><source>Open Access: PubMed Central</source><source>SpringerLink Journals</source><source>EZB Electronic Journals Library</source><creator>Raja, Anand ; Malik, Kanuj ; Kathiresan, N. ; Radhakrishnan, Venkatraman</creator><creatorcontrib>Raja, Anand ; Malik, Kanuj ; Kathiresan, N. ; Radhakrishnan, Venkatraman</creatorcontrib><description>Postchemotherapy RPLND remains an integral part of management of testicular tumours. Nerve-sparing techniques can minimize the ejaculatory dysfunction due to the procedure. We report our functional and oncological outcomes for nerve-sparing RPLND in postchemotherapy settings. We analysed data from all patients undergoing nerve-sparing PC RPLND from January 1990 to December 2013 at our institute. Antegrade ejaculation and fertility issues were determined by patient history. Nerve sparing was achieved in 30% of patients undergoing PC RPLND. Of the 33 patients who underwent nerve-sparing PC RPLND, 19 (57.8%) had antegrade ejaculation. The mean time to antegrade ejaculation was 6.8 months. After a median follow-up of 75.61 months, 5-year disease-free survival was 98%. Nerve-sparing RPLND can improve functional outcomes without increasing recurrence rates in post chemotherapy setting.</description><identifier>ISSN: 0975-7651</identifier><identifier>EISSN: 0976-6952</identifier><identifier>DOI: 10.1007/s13193-021-01313-9</identifier><identifier>PMID: 34295081</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Cancer surgery ; Medicine ; Medicine & Public Health ; Oncology ; Original ; Original Article ; Surgery ; Surgical Oncology</subject><ispartof>Indian journal of surgical oncology, 2021-06, Vol.12 (2), p.374-377</ispartof><rights>Indian Association of Surgical Oncology 2021</rights><rights>Indian Association of Surgical Oncology 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-3fcff3338dcf58657b21faadbff5cec282062996c906e9b9c065df0886a0ddd3</citedby><cites>FETCH-LOGICAL-c451t-3fcff3338dcf58657b21faadbff5cec282062996c906e9b9c065df0886a0ddd3</cites><orcidid>0000-0002-2585-8527</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272781/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272781/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids></links><search><creatorcontrib>Raja, Anand</creatorcontrib><creatorcontrib>Malik, Kanuj</creatorcontrib><creatorcontrib>Kathiresan, N.</creatorcontrib><creatorcontrib>Radhakrishnan, Venkatraman</creatorcontrib><title>Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre</title><title>Indian journal of surgical oncology</title><addtitle>Indian J Surg Oncol</addtitle><description>Postchemotherapy RPLND remains an integral part of management of testicular tumours. Nerve-sparing techniques can minimize the ejaculatory dysfunction due to the procedure. We report our functional and oncological outcomes for nerve-sparing RPLND in postchemotherapy settings. We analysed data from all patients undergoing nerve-sparing PC RPLND from January 1990 to December 2013 at our institute. Antegrade ejaculation and fertility issues were determined by patient history. Nerve sparing was achieved in 30% of patients undergoing PC RPLND. Of the 33 patients who underwent nerve-sparing PC RPLND, 19 (57.8%) had antegrade ejaculation. The mean time to antegrade ejaculation was 6.8 months. After a median follow-up of 75.61 months, 5-year disease-free survival was 98%. Nerve-sparing RPLND can improve functional outcomes without increasing recurrence rates in post chemotherapy setting.</description><subject>Cancer surgery</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>0975-7651</issn><issn>0976-6952</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9Ustu1DAUjRCIVqU_wMoSm7II-DF2YhZIKC0FaTSMyuwtj3PdcTW2g51UnZ_hW3E6FQgWeOMr33POffhU1WuC3xGMm_eZMCJZjSmpcQlZLZ9Vp1g2ohaS0-ePMa8bwclJdZ7zHS6HSbbA8mV1whZUctyS0-rnCtI91N8HnVy4ReuYR7MDH8cdJD0c0A2MKQ6Q3BgD6D1aHvywQ6vYA7p0OYMZXQzoYt2hm_VydfkW2ZhKOmTwLkSvxzhldA3Jow72e7SZfJzSB3T1MGtCMIBsih5ptIE0Op0OqNPlNRV4GBO8ql5Yvc9w_nSfVZvPV5vuS738dv21-7SszYKTsWbWWMsYa3tjeSt4s6XEat1vreUGDG0pFlRKYSQWILfSYMF7i9tWaNz3PTurPh5lh2nroTdzbb1XQ3K-tKSidurvTHA7dRvvVUsb2rSkCFw8CaT4Y4I8Ku-yKRPrAGUDinLOCW5kgwv0zT_Qu7KSUKabURhzQRZNQdEjyqSYcwL7uxmC1WwAdTSAKgZQjwZQspDYkZSH-Tch_ZH-D-sX5xK05w</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Raja, Anand</creator><creator>Malik, Kanuj</creator><creator>Kathiresan, N.</creator><creator>Radhakrishnan, Venkatraman</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2585-8527</orcidid></search><sort><creationdate>20210601</creationdate><title>Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre</title><author>Raja, Anand ; Malik, Kanuj ; Kathiresan, N. ; Radhakrishnan, Venkatraman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-3fcff3338dcf58657b21faadbff5cec282062996c906e9b9c065df0886a0ddd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer surgery</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raja, Anand</creatorcontrib><creatorcontrib>Malik, Kanuj</creatorcontrib><creatorcontrib>Kathiresan, N.</creatorcontrib><creatorcontrib>Radhakrishnan, Venkatraman</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raja, Anand</au><au>Malik, Kanuj</au><au>Kathiresan, N.</au><au>Radhakrishnan, Venkatraman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre</atitle><jtitle>Indian journal of surgical oncology</jtitle><stitle>Indian J Surg Oncol</stitle><date>2021-06-01</date><risdate>2021</risdate><volume>12</volume><issue>2</issue><spage>374</spage><epage>377</epage><pages>374-377</pages><issn>0975-7651</issn><eissn>0976-6952</eissn><abstract>Postchemotherapy RPLND remains an integral part of management of testicular tumours. Nerve-sparing techniques can minimize the ejaculatory dysfunction due to the procedure. We report our functional and oncological outcomes for nerve-sparing RPLND in postchemotherapy settings. We analysed data from all patients undergoing nerve-sparing PC RPLND from January 1990 to December 2013 at our institute. Antegrade ejaculation and fertility issues were determined by patient history. Nerve sparing was achieved in 30% of patients undergoing PC RPLND. Of the 33 patients who underwent nerve-sparing PC RPLND, 19 (57.8%) had antegrade ejaculation. The mean time to antegrade ejaculation was 6.8 months. After a median follow-up of 75.61 months, 5-year disease-free survival was 98%. Nerve-sparing RPLND can improve functional outcomes without increasing recurrence rates in post chemotherapy setting.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>34295081</pmid><doi>10.1007/s13193-021-01313-9</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-2585-8527</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0975-7651 |
| ispartof | Indian journal of surgical oncology, 2021-06, Vol.12 (2), p.374-377 |
| issn | 0975-7651 0976-6952 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8272781 |
| source | Open Access: PubMed Central; SpringerLink Journals; EZB Electronic Journals Library |
| subjects | Cancer surgery Medicine Medicine & Public Health Oncology Original Original Article Surgery Surgical Oncology |
| title | Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nerve-Sparing%20Postchemotherapy%20Retroperitoneal%20Lymph%20Node%20Dissection%20(PC%20RPLND)%20for%20Nonseminomatous%20Germ%20Cell%20Tumour:%20Experience%20from%20a%20Tertiary%20Cancer%20Centre&rft.jtitle=Indian%20journal%20of%20surgical%20oncology&rft.au=Raja,%20Anand&rft.date=2021-06-01&rft.volume=12&rft.issue=2&rft.spage=374&rft.epage=377&rft.pages=374-377&rft.issn=0975-7651&rft.eissn=0976-6952&rft_id=info:doi/10.1007/s13193-021-01313-9&rft_dat=%3Cproquest_pubme%3E2550056147%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2550056147&rft_id=info:pmid/34295081&rfr_iscdi=true |